Also, we explored the expression of SIGLEC-5 and VISTA as ligands in monocytes from patients with OSA and control subjects and investigated the regulatory role of intermittent hypoxia on the PSGL-1 axis using different in vitro models. This evidence concerns the gene VSIR and obstructive sleep apnea syndrome.